NEI Research News

Three studies reported in Nature Genetics have converged on the same gene as a rare, but powerful risk factor for age-related macular degeneration (AMD), a common cause of vision loss in older people.

The standard treatment for amblyopia, a condition of poor vision in an otherwise healthy eye, is patching: covering a child’s better-seeing eye with a patch for two hours a day to improve vision in the weaker eye.

A class of proteins that controls visual system development in the young brain also appears to affect vulnerability to Alzheimer’s disease in the aging brain.

Researchers from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), working with researchers in Iceland, have found that hearing impairment and dual sensory impairment (vision and hearing impairment combined)

A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain.

The National Eye Institute (NEI) has announced funding opportunities for two new high priority research areas.

Researchers are making progress toward understanding how some cases of glaucoma begin.

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria—the energy factories within cells.

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye.

Ronald Davis, Ph.D., an NEI grantee and a geneticist at Stanford University School of Medicine, has been selected to receive an award from the Warren Alpert Foundation.